Zhengzhou Fuqing Network Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhengzhou Fuqing Network Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SLEVEPTPUS. The owner is based in Zhengzhou, Henan.

Shilihe St, Guancheng Hui Dist,

3103, Unit 1, Bldg 3, Zeyuan, CGTC,

Zhengzhou, Henan 450061 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhengzhou Fuqing Network Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhengzhou Fuqing Network Technology Co., Ltd. have?

Zhengzhou Fuqing Network Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhengzhou Fuqing Network Technology Co., Ltd. file in?

Zhengzhou Fuqing Network Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhengzhou Fuqing Network Technology Co., Ltd.'s most well-known trademarks?

Zhengzhou Fuqing Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SLEVEPTPUS. These are among 1 currently registered trademark in the portfolio.

What is Zhengzhou Fuqing Network Technology Co., Ltd.'s trademark registration success rate?

Zhengzhou Fuqing Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.